NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

They can fille in any order. But the entire point of ORBIS is to allow others to share in the FDA review, which runs on the FDA timeline.

On "cost neutral".

For EAMS the product is supplied by the manufacturer free to NICE. So that does not matter

For "cost neutral" temporary reimbursement, you are correct that does not mean no profits. What it does mean is that overall cost to NICE is the same as the treatments it replaces. Problem is, DCVax-L is additive to SOC.